In recent GLP-1RA trials focusing on patients with obesity, favourable effect on worsening heart failure in HFpEF patients was indicated to be modulated by baseline BMI [32], although the underlying mechanisms that explain the cardiovascular and renal benefits may not necessarily be due to weight loss alone
doi:10.1212/WNL.0b013e3182a8236e 4PeriquetMI, NovakV, CollinsMP,
Compounded GLP-1 medications operate under FDA section 503A oversight and state pharmacy regulation
Track weight, energy, sleep, and mood to witness true advancement
This study enrolled adults with obesity (body mass index 30 kg/m) without type 2 diabetes, and a separate cohort with type 2 diabetes, across multiple international sites
But what were going to do for you is were going to work with you to design a program that this becomes the very last time we ever talk about quote unquote diets